Itron (NASDAQ:ITRI) Issues Earnings Results

Itron (NASDAQ:ITRI) released its quarterly earnings data on Tuesday. The scientific and technical instruments company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.26 by $0.23, FiscalAI reports. The firm had revenue of $586.98 million for the quarter, compared to the consensus estimate of $572.13 million. Itron had a net margin of 12.72% and a return on equity of 20.04%. The company’s quarterly revenue was down 3.3% on a year-over-year basis. During the same period in the previous year, the company earned $1.52 earnings per share. Itron updated its Q2 2026 guidance to 1.250-1.350 EPS.

Here are the key takeaways from Itron’s conference call:

• Itron beat expectations in Q1 with $587M revenue, $92M adjusted EBITDA, $1.49 non?GAAP EPS and $79M free cash flow while adjusted gross margin widened ~490 bps to 40.7%.
• Bookings were $476M and backlog ended the quarter at $4.4B, supporting multi?year visibility, but Q2 guidance of $560–$570M (midpoint down ~7% YoY) reflects near?term timing effects.
• Recurring and outcomes businesses are growing quickly — Outcomes revenue rose 22% YoY and total company ARR reached $414M (up 28%), driving more predictable, higher?margin revenue.
• The Resiliency Solutions acquisitions (Urbint and Locusview) contributed $16M in Q1, are integrating on track, and management expects them to be accretive to growth, gross margin and EBITDA (EPS accretive by 2027).
• Management emphasized lumpy network deployments and timing risk — second?half growth depends on converting large network projects, and macro/regulatory volatility could affect deployment schedules.

Itron Price Performance

NASDAQ:ITRI traded up $1.31 during trading hours on Thursday, reaching $84.00. 511,130 shares of the company were exchanged, compared to its average volume of 975,212. The business has a 50 day moving average of $92.42 and a 200 day moving average of $99.56. Itron has a 1-year low of $78.53 and a 1-year high of $142.00. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.80 and a quick ratio of 1.56. The company has a market capitalization of $3.72 billion, a P/E ratio of 12.87, a P/E/G ratio of 0.77 and a beta of 1.50.

Insider Activity

In related news, CAO David Marshall Wright sold 264 shares of the business’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $100.17, for a total value of $26,444.88. Following the completion of the transaction, the chief accounting officer owned 9,124 shares of the company’s stock, valued at $913,951.08. The trade was a 2.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Christopher E. Ware sold 763 shares of the company’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $100.17, for a total transaction of $76,429.71. Following the sale, the senior vice president directly owned 31,043 shares of the company’s stock, valued at $3,109,577.31. This represents a 2.40% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 51,180 shares of company stock worth $5,085,475. 1.77% of the stock is owned by insiders.

Institutional Trading of Itron

A number of institutional investors and hedge funds have recently made changes to their positions in ITRI. Dimensional Fund Advisors LP increased its stake in Itron by 18.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,271,042 shares of the scientific and technical instruments company’s stock valued at $118,034,000 after acquiring an additional 194,768 shares during the last quarter. First Trust Advisors LP lifted its stake in Itron by 4.1% during the fourth quarter. First Trust Advisors LP now owns 793,175 shares of the scientific and technical instruments company’s stock worth $73,654,000 after purchasing an additional 31,088 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Itron by 42.5% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 604,580 shares of the scientific and technical instruments company’s stock valued at $75,306,000 after purchasing an additional 180,366 shares in the last quarter. Schroder Investment Management Group boosted its holdings in shares of Itron by 65.2% in the 4th quarter. Schroder Investment Management Group now owns 588,872 shares of the scientific and technical instruments company’s stock valued at $54,683,000 after purchasing an additional 232,341 shares in the last quarter. Finally, Millennium Management LLC increased its stake in shares of Itron by 269.3% in the 4th quarter. Millennium Management LLC now owns 506,867 shares of the scientific and technical instruments company’s stock valued at $47,068,000 after purchasing an additional 369,617 shares during the last quarter. Institutional investors own 96.19% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on ITRI shares. Robert W. Baird set a $128.00 target price on shares of Itron and gave the stock an “outperform” rating in a report on Wednesday, February 18th. Weiss Ratings downgraded shares of Itron from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 12th. JPMorgan Chase & Co. decreased their target price on Itron from $133.00 to $113.00 and set an “overweight” rating on the stock in a research report on Thursday, April 16th. Needham & Company LLC assumed coverage on Itron in a research note on Friday, March 6th. They set a “buy” rating and a $124.00 target price on the stock. Finally, Roth Mkm reissued a “buy” rating and set a $136.00 price target on shares of Itron in a report on Wednesday. Eight investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $130.20.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.